C
DFTX

Covestor’s Definium Therapeutics DFTX Stock Holding History

Covestor’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
+27
New +$667 ﹤0.01% 2235

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Covestor's DFTX Position: Q2 2026 in Review

Covestor opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 27 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2235 among its holdings.

160 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Covestor held 27 shares of Definium Therapeutics worth $1K as of Q2 2026.
  • Definium Therapeutics was a new Covestor position in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2235 holding.
  • 160 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.